Publication | Closed Access

Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)

OncologyFoca TrialMedicineColorectal CancerGoam Phase IiPharmacotherapySurgeryCancer TreatmentAdvanced Colorectal CancerPharmacologyRadiation OncologyCancer Research